Press Releases
Sense, Phillips-Medisize partner to speed up production of new COVID-19 test
Sense has announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Sense is partnering closely with Phillips-Medisize, a Molex company and leading global medical device innovator,...
Press Releases
Cellex gets FDA authorization for COVID-19 antibody test
The agency granted an emergency use authorization to the company for its test, which is meant to detect antibodies against SARS-CoV-2 in the blood. However, antibody testing has both advantages and disadvantages relative to the more common PCR assays.
The...
Drug Research
Zymo Research Announces Partnership with Tecan for COVID-19 Viral RNA Extraction
Zymo Research announced a partnership with Tecan to launch a ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma, and serum. The DreamPrep™ NAP workstation, featuring Zymo Research’s Quick-DNA/RNA™ Viral MagBead Kit,...
Press Releases
PCR Biosystems continues to scale up operations to ensure ongoing availability of COVID-19 test reagents
PCR Biosystems, the UK-based PCR experts, are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises. To meet current and...
Press Releases
Expert System Grants Researchers Access to AI-Based CRN Tool
Expert System joins the fight against COVID-19 by granting biomedical researchers worldwide free access to its AI-based Clinical Research Navigator (CRN) tool effective immediately and extending through at least July 1. CRN contains a structured real-time data set of...
Drug Research
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and...
Press Releases
Ultragenyx Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Technology
Ultragenyx Pharmaceutical Inc , a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, announced a strategic partnership and non-exclusive license and technology access agreement with Daiichi Sankyo Company, Limited for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.